3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C39H49NO9 — CID 90348195

IUPAC3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCCCOc1c2c(cc3c1C(=O)N[C@@H]1C3=C[C@H](O)[C@@H](O)[C@H]1O)OCO2
InChIInChI=1S/C39H49NO9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-32(42)46-23-21-24-47-38-33-28(26-31-37(38)49-27-48-31)29-25-30(41)35(43)36(44)34(29)40-39(33)45/h3-4,6-7,9-10,12-13,15-16,18-19,25-26,30,34-36,41,43-44H,2,5,8,11,14,17,20-24,27H2,1H3,(H,40,45)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-/t30-,34+,35+,36-/m0/s1
InChIKeyIQWJTLICMPAKAW-LIHIFWLNSA-N
MW675.82 g/mol
LogP5.80
Rot. Bonds19

About 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate (PubChem CID 90348195) has the molecular formula C39H49NO9 and a molecular weight of 675.82 g/mol. Its IUPAC name is 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate.

Molecular Properties

Compound Name3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
PubChem CID90348195
Molecular FormulaC39H49NO9
Molecular Weight675.82 g/mol
Exact Mass675.34
IUPAC Name3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCCCOc1c2c(cc3c1C(=O)N[C@@H]1C3=C[C@H](O)[C@@H](O)[C@H]1O)OCO2
InChIInChI=1S/C39H49NO9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-32(42)46-23-21-24-47-38-33-28(26-31-37(38)49-27-48-31)29-25-30(41)35(43)36(44)34(29)40-39(33)45/h3-4,6-7,9-10,12-13,15-16,18-19,25-26,30,34-36,41,43-44H,2,5,8,11,14,17,20-24,27H2,1H3,(H,40,45)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-/t30-,34+,35+,36-/m0/s1
InChIKeyIQWJTLICMPAKAW-LIHIFWLNSA-N
XLogP5.80
TPSA143.78 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds19
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500675.82
LogP ≤ 55.80
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate?
The IUPAC name of 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate (CID 90348195) is 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate.
What is the SMILES notation for 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate?
The canonical SMILES for 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCCCOc1c2c(cc3c1C(=O)N[C@@H]1C3=C[C@H](O)[C@@H](O)[C@H]1O)OCO2.
What is the InChIKey of 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate?
The InChIKey is IQWJTLICMPAKAW-LIHIFWLNSA-N. The full InChI is InChI=1S/C39H49NO9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-32(42)46-23-21-24-47-38-33-28(26-31-37(38)49-27-48-31)29-25-30(41)35(43)36(44)34(29)40-39(33)45/h3-4,6-7,9-10,12-13,15-16,18-19,25-26,30,34-36,41,43-44H,2,5,8,11,14,17,20-24,27H2,1H3,(H,40,45)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-/t30-,34+,35+,36-/m0/s1.
What are the key properties of 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate?
3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate has a molecular weight of 675.82 g/mol, XLogP of 5.80, 19 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[(2S,3R,4S,4aR)-2,3,4-trihydroxy-6-oxo-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-7-yl]oxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate is sourced from PubChem (CID 90348195), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).